Nemvaleukin,pembrolizumab
alkermes,merck
['ovarian']
a new #clinicaltrial, artistry-7, studying the effectiveness of a combination of #immunotherapy treatments could be more effective for patients with #ovariancancer who are resistant to traditional interventions: #asco22 #oncnews 
Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology